Long-acting Lipoglycopeptides for the Treatment of Gram-positive Infections in Children: Evidence and Real-life Experience With Dalbavancin and Oritavancin. (PubMed, Pediatr Infect Dis J) - Oct 8, 2026 - No abstract available Journal • Infectious Disease
|
|
Anna Gamell; David Aguilera-Alonso; Eneritz Velasco-Arnaiz; María Goretti López-Ramos
|